Two Sigma Investments’s TherapeuticsMD TXMD Stock Holding History

Two Sigma Investments’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,673	Closed	-$65K	–	4312
2021 Q4	$65K	Buy	3,673 +3,226	+722%	+$96.7K	﹤0.01%	4121
2021 Q3	$17K	Buy	+447	New	+$19.8K	﹤0.01%	4170
2021 Q2	–	Sell	-9,837	Closed	-$659K	–	4577
2021 Q1	$659K	Buy	+9,837	New	+$770K	﹤0.01%	2673
2020 Q3	–	Sell	-2,524	Closed	-$158K	–	3569
2020 Q2	$158K	Sell	2,524 -151	-6%	-$8.79K	﹤0.01%	2703
2020 Q1	$142K	Sell	2,675 -21,469	-89%	-$2.13M	﹤0.01%	2761
2019 Q4	$2.92M	Buy	+24,144	New	+$3.47M	0.01%	1298
2016 Q4	–	Sell	-224	Closed	-$76K	–	3524
2016 Q3	$76K	Buy	+224	New	+$81.8K	﹤0.01%	3034

Other funds holding TXMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Two Sigma Investments's TXMD Position: Q1 2022 in Review

Two Sigma Investments sold out of TherapeuticsMD (TXMD) in Q1 2022, closing a stake of 3,673 shares — an estimated $65K sold.

Two Sigma Investments first reported a position in TXMD in Q3 2016 and held it in 7 quarters. The position peaked at $2.92M in Q4 2019. 124 funds tracked by Wall St. Rank hold TXMD as of Q1 2022.

Two Sigma Investments reported no remaining TherapeuticsMD position as of Q1 2022 after selling out during the quarter.
Two Sigma Investments sold 3,673 TherapeuticsMD shares in Q1 2022, an estimated $65K.
Two Sigma Investments first reported a position in TherapeuticsMD in Q3 2016 and held it in 7 quarters.
Two Sigma Investments's TherapeuticsMD position peaked at $2.92M in Q4 2019.
124 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2022.

Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.